Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight: Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1871 - 1880 of 1890 results

First page
Previous page
188
Next page
Next page

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

69H0YJ871T

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

2I1EOL437M

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

Class:

CONCEPT

INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

K5313H4VGS

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

INFLUENZA B VIRUS B/BRISBANE/60/2008 RECOMBINANT HEMAGGLUTININ ANTIGEN

058U2312CR

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

Class:

CONCEPT

INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 RECOMBINANT HEMAGGLUTININ ANTIGEN

AYR0WZX7JH

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

Class:

CONCEPT

INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN

N9C76986U2

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

INFLUENZA A VIRUS A/TEXAS/50/2012 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

1IQZ1WCE3Y

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

Class:

CONCEPT

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

1SE9Z7D2QR

Status:

US Approved Rx (2013)

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

PLASMA PROTEIN FRACTION (HUMAN)

6D53G0FD0Z

Status:

US Approved Rx (2013)

Source:

BLA125416

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e629b5ce-f4e8-59d7-5000-cc874da27d2a

First approved in 2013

Source:

BLA125416

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e629b5ce-f4e8-59d7-5000-cc874da27d2a

Class:

CONCEPT

BELIMUMAB

73B0K5S26A

Status:

US Approved Rx (2017)

Source:

BLA761043

(2017)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761043

First approved in 2011

Source:

BLA125370

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125370

Class:

CONCEPT

Concept

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/BRISBANE/60/2008 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/TEXAS/50/2012 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

PLASMA PROTEIN FRACTION (HUMAN)

Concept

BELIMUMAB

Showing 1871 - 1880 of 1890 results

First page
Previous page
188
Next page
Next page

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1